Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Bgc Notes: Alternative & Special Situations Value Investing – Verdad, Bluemountain And More – Valuewalk Premium
Private Equity

Bgc Notes: Alternative & Special Situations Value Investing – Verdad, Bluemountain And More – Valuewalk Premium

by valuewalkpremium.com posted 2weeks ago 151 views
Notes from the Alternative and Special Situations Value Investing Panel featuring Verdad Capital's Brian Chingono, CarVal Investors' William Schatz, Bluemountain Capital's Omar Vaishnavi, and Wincrest Capital's Barbara Ann Bernard from the 2019 Ben Graham VI Annual Conference, which took place on Wednesday, June 19. Abbott Laboratories (NYSE:ABT) Abbott Laboratories (NYSE:ABT) is scheduled to release its Q2 2013 earnings results before the market open on Wednesday, July 17.